Exchange: NASDAQ·Updated 01:55 PM EDT
BDTX logo

BDTX Black Diamond Therapeutics Inc

$1.65
$0.04
(2.37%)
Today
EarningsNov 5
Mkt Cap$97.1M
Vol368,138.00

About BDTX

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
72

Bullish Sentiment

How do you feel about BDTX?

e999
$BDTX It feels a bit secretive, but this company does mention the progress every month. It was only quiet in October. The data is so strong that we have to wait for the results, but with three catalysts clustered together, short sellers should stay alert.
1
4
e999
$BDTX I also have no doubt about their data. The only disappointing thing is that the company's follow-up response afterward was too closed off. Ultimately, this is being reflected in the stock price. At the very least, they should have said something to reassure the shareholders. I won't mention other cases of soaring biotech companies, but generally, their response was swift. Ofc, I want to believe that this is an embargo.
1
2
BossTrade
$BDTX There’s a blackout period between financials and material news. They cannot legally release material news before Q3 financials
1
1
chole1
$BDTX the ask side is always filled with 1000s of shares every cent, looks like institutional selling, or shorting/hedging, but not sure given short interest not going up these days.... a day in green would be time
1
superalby
$BDTX i dont know about algos or graphics. I just know that when Dr.Julia Rotow and Dr. Patrick Wen spend their time to praise silevertinib... its a VERY good sign.
1
3
bph082672
$BDTX Hopefully this is the shake out! Ridiculous. Nice if company threw surprise tomatoes AM
1
3
superalby
$BDTX NDA alert...Has anyone seen Mark Velleca? 🔎 Missing for weeks. Last seen heading into FDA headquarters with a Phase 3 study plan and a cup of coffee. ​If found, please return him to $BDTX investors immediately. Reward offered: 5x stock price after PR announcement. 🚨😅
5
e999
$BDTX $BDTX Is it an embargo, or is it just silence? Or are they preparing for it? It was fine until the Piper Sandler time???
1
chole1
$BDTX ok, no wonder it is down heavy ever day! - NO news on FDA re the NSCLC trial(s) - NO news on partnership/financing required for the NSCLC trial(s) - NO update re mature pfs from P2 1st line NSCLC trial - NO update if part 2 of the GBM study has initiated or if there are issues - NO update / nor milestone from Servier since the deal 2.5 years ago - NO investor relations work / active marketing to investors turns into my worst investment with the team just disappeared, which means they either hide behind the Q3 quiet period or hopefully due to the waiting time for the written FDA communication Will be painful until they start to address these topics, which they should have started to do so yesterday
1
BossTrade
$BDTX The company CEO and co founder have a fireside chat tomorrow @ piper sandler virtual symposium at 130pm We can’t attend unfortunately looks like
1
2
I_am_retail_investor
$BDTX - when are the deep pockets planning to get off the bunny slope and onto the black diamond?
1
2
RyanS219
$BDTX Might the Arrivent failure with Firmonertinib be a factor in the share price falling? Their compound has an overlapping mechanism of action with silvertinib.
1
frankwa
unreal how $BDTX takes 1 step forward and 2 steps back. Ive been in this stock for 3 years but this is frustrating that it couldnt hold $2.00 for more than a few days. I was starting to believe that it was consolidating but now today it feels like its back in a free fall.
1
1
superalby
$BDTX Nearly a decade in for early backers NEA and Versant in $BDTX. With FDA answer for silevertinib pivotal in few weeks and the VC fund lifecycle winding down, M&A is the logical play. Time to unlock value ... 🚀
1
1
I_am_retail_investor
$BDTX - nice to see this ticker symbol maybe graduating from the baby green circle to more advanced blue square trading range, on its way to true Black Diamond [hands]
4
BossTrade
$BDTX If FDA gives this single arm registrations trial for silevertinib (as was discussed briefly on the Sept 15 call is what they want) then share price will explode. It will cut path to commercialization by at least 2 years and basically secure a big pharma partnership Don’t pass out if it hits $20 when that happens
2
bph082672
$BDTX Whats going on alread?. Time for update or some news. Love company; but this is getting old and alarming
1
1
chole1
$BDTX hmmm.... biotech flying and ZERO care about BDTX... they better get their act together soon
1
1
frankwa
$BDTX Whats up with the large candle to close/after hours? Is it an algo washing a trade from the 1st large green candle? Both candles are 314k and 311k volume.
1
Tusinvestor
$BDTX congrats everyone! 2,35% gain today, definitely on the TOP 10 days with more gains of the last 6 years. Let's go

Advertisement|Remove ads.